▟ Vinebot intrinsic value, daily

← back

TRV Travelers Companies (The)

insurance · valued with opus medium conviction · deep-dived 2026-10-28

HOLD
Intrinsic value$272.48
Price (at call)$397.03
Margin of safety -31.4%
vs market (rating basis) -13.7%

Elite underwriter, but the stock prices in 25% ROE that a normal cat year erases.

The story

Travelers is a best-in-class commercial and personal lines underwriter with disciplined pricing, a conservative reserve position, and a high-quality, mostly investment-grade fixed-income portfolio. Trailing ROE of about 25% comes from a benign catastrophe year, favorable prior-year reserve development, and a peak in the commercial pricing cycle. All three tend to mean-revert, and commercial rate increases are already decelerating. Leverage is modest and capital is strong, but the market price implies peak returns will persist.

I raised normalized ROE slightly, from 15.5% to 16%, because a second straight year of strong underwriting and higher reinvestment yields support a somewhat higher mid-cycle level. A normal catastrophe load and softer pricing still pull returns well below the trailing 25%. Book growth stays at about 7% because heavy buybacks absorb much of the earnings. Terminal growth of 4% stays below the 4.99% risk-free rate, and the beta remains slightly below the industry anchor given the stable franchise.

Value drivers

Return on equity (normalized)16.0%
Book-value growth (Y1)7.0%
Terminal book growth4.0%
Beta0.82
Failure probability1.0%
Cost of equity8.7%

Valuation bridge

PV of excess returns13.07B
PV of terminal excess10.43B
Equity value55.83B
÷ shares → per share$272.48

Projected excess returns on equity

YrBook equityROEExcess returnPV
132.89B 16.0%2.41B 2.21B
235.20B 15.4%2.37B 2.00B
337.54B 14.8%2.30B 1.79B
439.92B 14.2%2.21B 1.59B
542.32B 13.6%2.10B 1.38B
644.71B 13.0%1.95B 1.18B
747.10B 12.5%1.78B 991.94M
849.45B 11.9%1.57B 808.25M
951.76B 11.3%1.34B 633.84M
1054.00B 10.7%1.08B 469.72M

Key risks

  • Softening commercial pricing and a reversal of reserve releases compress the combined ratio toward the mid-90s
  • Severe catastrophe year or rising secondary-peril frequency (convective storms, wildfire)
  • Social inflation and adverse development in casualty and umbrella lines

Catalysts

  • Underlying combined ratio staying below 88% through the 2027 renewal season would validate a higher normalized ROE
  • Investment income rising as the portfolio rolls into higher yields

History

DatePriceIntrinsicMoSRating
2026-10-28$397.03 $272.48 -31.4% HOLD
2026-09-25$362.39 $260.28 -28.2% HOLD
2026-08-25$370.55 $300.82 -18.8% HOLD
2026-07-23$372.08 $265.82 -28.6% HOLD
2026-06-23$316.96 $265.57 -16.2% HOLD